Home » Topics » Regulatory

Regulatory
RSS

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Anticonvulsants for cluster headache

Sep. 6, 2000

Topiramate has beneficial effects in transformed migraine

Sep. 6, 2000

Tripedia receives FDA approval for use in the entire DTP immunization series

Sep. 6, 2000

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000

Zometa approved in Canada for treatment of tumor-induced hypercalcemia

Aug. 31, 2000

Tablet form of Rapamune receives FDA approval

Aug. 30, 2000

New findings on an old drug: metformin

Aug. 3, 2000

Clinical trial results disappointing for Provigil as treatment for adult ADHD

Aug. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...